TickerFactsScreenerDevelopers

Ernexa Therapeutics Inc. (ERNA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $1.32M2011: $1.59M2012: $1.23M2013: $1.11M2014: $835.0K2015: $991.0K2016: $427.0K2017: $728.0K2018: $648.0K2019: $128.0K2020: $39.0K2021: $154.0K2022: $297.0K2023: $19.0K2024: $369.0K2025: $37.0K$37.0K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$37.0K-90.0%
2024$369.0K+1842.1%
2023$19.0K-93.6%
2022$297.0K+92.9%
2021$154.0K+294.9%
2020$39.0K-69.5%
2019$128.0K-80.2%
2018$648.0K-11.0%
2017$728.0K+70.5%
2016$427.0K-56.9%
2015$991.0K+18.7%
2014$835.0K-24.7%
2013$1.11M-9.5%
2012$1.23M-23.1%
2011$1.59M+20.5%
2010$1.32M—